HLA-G gene repression is reversed by demethylation

被引:136
作者
Moreau, P
Mouillot, G
Rousseau, P
Marcou, C
Dausset, J
Carosella, ED
机构
[1] Hop St Louis, Inst Univ Hematol, CEA,Serv Rech Hamatoimmunol, Direct Sci Vivant,Dept Rech Med, F-75010 Paris, France
[2] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France
关键词
D O I
10.1073/pnas.0337539100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The HLA-G molecule plays an important role in immune tolerance, protecting the fetus from maternal immune attack, and probably contributes to graft tolerance and tumor escape from the host immune system. HLA-G expression is tightly regulated and involves mechanisms acting in part at the transcriptional level. Nevertheless, almost all regulatory sequences that govern constitutive and inducible HLA class I gene transcription are disrupted in the HLA-G gene promoter, suggesting an unusual regulatory process. In further investigating the molecular mechanisms of HLA-G gene activation, we evaluated the influence of epigenetic mechanisms on seven HLA-G-negative cell lines that exhibit various phenotypes. Exposure of cells to histone deacetylase inhibitors, or to the demethylating agent 5-aza-2'-deoxycytidine, revealed that HLA-G gene transcription is inhibited by DNA methylation. Reversal of methylation-mediated repression may directly induce HLA-G cell-surface expression, supporting the idea that HLA-G might be activated by such a mechanism during malignancy, inflammation, and allogenic reactions.
引用
收藏
页码:1191 / 1196
页数:6
相关论文
共 71 条
[61]  
Ugurel S, 2001, CANCER, V92, P369, DOI 10.1002/1097-0142(20010715)92:2<369::AID-CNCR1332>3.0.CO
[62]  
2-U
[63]   HLA-G in melanoma: A new strategy to escape from immunosurveillance? [J].
Ugurel, S ;
Reinhold, U ;
Tilgen, W .
ONKOLOGIE, 2002, 25 (02) :129-134
[64]   BLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas [J].
Urosevic, M ;
Willers, J ;
Mueller, B ;
Kempf, W ;
Burg, G ;
Dummer, R .
BLOOD, 2002, 99 (02) :609-617
[65]   Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production [J].
Urosevic, M ;
Kurrer, MO ;
Kamarashev, J ;
Mueller, B ;
Weder, W ;
Burg, G ;
Stahel, RA ;
Dummer, R ;
Trojan, A .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (03) :817-824
[66]   Shared regulatory elements in the promoters of MHC class I and class II genes [J].
van den Elsen, PJ ;
Peijnenburg, A ;
van Eggermond, MCJA ;
Gobin, SJP .
IMMUNOLOGY TODAY, 1998, 19 (07) :308-312
[67]   Transcriptional control of MHC genes in fetal trophoblast cells [J].
van den Elsen, PJ ;
Gobin, SJP ;
van der Stoep, N ;
Datema, G ;
Viëtor, HE .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2001, 52 (1-2) :129-145
[68]   Methyl CpG-binding transcriptional proteins and repression [J].
Wade, PA .
BIOESSAYS, 2001, 23 (12) :1131-1137
[69]   A functional role of HLA-G expression in human gliomas: An alternative strategy of immune escape [J].
Wiendl, H ;
Mitsdoerffer, M ;
Hofmeister, V ;
Wischhusen, J ;
Bornemann, A ;
Meyermann, R ;
Weiss, EH ;
Melms, A ;
Weller, M .
JOURNAL OF IMMUNOLOGY, 2002, 168 (09) :4772-4780
[70]   Chromatin remodeling: why it is important in cancer [J].
Wolffe, AP .
ONCOGENE, 2001, 20 (24) :2988-2990